Quantitative DNA methylation analysis of genes coding for kallikrein-related peptidases 6 and 10 as biomarkers for prostate cancer.
about
Involvement of Kallikrein-Related Peptidases in Normal and Pathologic ProcessesEmerging clinical importance of the cancer biomarkers kallikrein-related peptidases (KLK) in female and male reproductive organ malignanciesEpigenomic profiling of prostate cancer identifies differentially methylated genes in TMPRSS2:ERG fusion-positive versus fusion-negative tumors.DNA methylation profiling reveals novel diagnostic biomarkers in renal cell carcinoma.Kallikrein-related peptidase 6 regulates epithelial-to-mesenchymal transition and serves as prognostic biomarker for head and neck squamous cell carcinoma patientsNES1/KLK10 gene represses proliferation, enhances apoptosis and down-regulates glucose metabolism of PC3 prostate cancer cells.The Role of Chromosomal Instability and Epigenetics in Colorectal Cancers Lacking β-Catenin/TCF Regulated TranscriptionOverexpression of kallikrein gene 10 is a biomarker for predicting poor prognosis in gastric cancer.Novel multiplex MethyLight protocol for detection of DNA methylation in patient tissues and bodily fluids.Targeting kallikrein-related peptidases in prostate cancer.Predictions for the future of kallikrein-related peptidases in molecular diagnostics.Prognostic DNA methylation markers for prostate cancer.Kallikrein-related peptidases targeted therapies in prostate cancer: perspectives and challenges.DNA Methylation and Urological Cancer, a Step Towards Personalized Medicine: Current and Future Prospects.Putative functions of tissue kallikrein-related peptidases in vaginal fluid.Kallikrein-Related Peptidases in Prostate Cancer: From Molecular Function to Clinical ApplicationA cancer specific hypermethylation signature of the TERT promoter predicts biochemical relapse in prostate cancer: a retrospective cohort study.DNA methylation screening of primary prostate tumors identifies SRD5A2 and CYP11A1 as candidate markers for assessing risk of biochemical recurrence.A panel of DNA methylation markers reveals extensive methylation in histologically benign prostate biopsy cores from cancer patients.Epigenetic biomarkers: Current strategies and future challenges for their use in the clinical laboratory.DNA methylation profiling of well-differentiated thyroid cancer uncovers markers of recurrence free survival.
P2860
Q26771266-D4CEC511-0C7E-4463-BA21-4D628E231CC0Q27007065-CA257C76-85E1-4402-9530-60D62AB962AAQ27323950-8A79C927-4987-44F0-99CC-256BEFD6173CQ34694198-9930B2DE-7A03-4567-AF05-F073BF499DF3Q35623800-14E8486C-33D0-4828-937F-37D7F879E00FQ36329646-A3B9E711-0C4B-494E-BBCB-4EBBAEBF9C74Q36707302-53F0A83B-44CE-4723-8332-7D87BC277141Q37440009-559EA307-2845-4F94-9C72-B43E29A3FF71Q37653469-065B6BD1-F8D3-4D0C-931B-5F688B0EC08CQ38191293-9FBE6ED5-291C-49EE-9139-FCB4F59C733AQ38220044-7E9260AB-5393-4505-A970-44A48C8C89C9Q38252624-53490762-1096-4281-99AE-9A26A14D7824Q38413737-4C6AD616-0079-4E10-93D1-C5EC58D4459DQ38833395-3DBEAD81-182F-4AA4-A4D4-F2380F66561BQ38948393-E157BCE3-F83D-4FA4-B9FF-CCB2D3A5062CQ38967490-A3DE1FEF-0EF5-4108-B46B-B6F2BB178B38Q39581362-C05FC278-E3AD-4208-B046-366E25104DCDQ40581966-EF361839-F889-477C-8FE3-9F81FC80AE1CQ43083508-4170BEE6-E1D8-463E-9BB1-7863BB6AFBB8Q47789662-674DE0F1-8A6A-4780-A578-7BC6876110E2Q54387117-08F99995-BEA6-4E3C-8EA6-232F6132F226
P2860
Quantitative DNA methylation analysis of genes coding for kallikrein-related peptidases 6 and 10 as biomarkers for prostate cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Quantitative DNA methylation a ...... iomarkers for prostate cancer.
@ast
Quantitative DNA methylation a ...... iomarkers for prostate cancer.
@en
type
label
Quantitative DNA methylation a ...... iomarkers for prostate cancer.
@ast
Quantitative DNA methylation a ...... iomarkers for prostate cancer.
@en
prefLabel
Quantitative DNA methylation a ...... iomarkers for prostate cancer.
@ast
Quantitative DNA methylation a ...... iomarkers for prostate cancer.
@en
P2093
P2860
P356
P1433
P1476
Quantitative DNA methylation a ...... iomarkers for prostate cancer.
@en
P2093
Alexandre R Zlotta
Bharati Bapat
Christine Massey
Ekaterina Olkhov-Mitsel
Franz Recker
Hilmi Ozcelik
Ken J Kron
Laurent Briollais
Maciej Kwiatkowski
Neil E Fleshner
P2860
P304
P356
10.4161/EPI.21524
P577
2012-08-09T00:00:00Z